1-cyclohexyl-4- (1,2-diphenylethyl)piperazine (‘MT-45’)
In April 2014, the EMCDDA and Europol examined the available information on a new psychoactive substance 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine, commonly known as MT-45.
Annual accounts 2013
The financial statements of the EMCDDA and the reports on implementation of the budget.
In February 2014, the EMCDDA and Europol examined the available information on a new psychoactive substance, 4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (commonly known by the abbreviation 4,4′-DMAR).
Residential treatment for drug use in Europe
The aim of this paper is to provide a Europe-wide overview of the history and availability of residential drug treatment within wider national drug treatment systems.
This report presents the key activities performed by the EMCDDA and Europol in 2013.